Humanizing mice for the identification of novel anticancer lipids targeting iNKT cells

Area of Science:

• Immunology
• Oncology
• Innate Immunity

Background:

• Natural killer T (NKT) cells are crucial immune cells that recognize lipid antigens presented by CD1d molecules.
• The innate immune system relies on CD1d-restricted NKT cell activation.
• Current NKT-cell agonist-based cancer therapies have shown limited efficacy.

Purpose of the Study:

• To develop a humanized mouse model for studying the CD1d/NKT cell antigen presentation system.
• To identify novel lipid antigens with antineoplastic functions targeting NKT cells.
• To improve the preclinical evaluation of NKT-cell-based immunotherapies.

Main Methods:

• Generation of genetically modified mice expressing human CD1d and NKT cell receptors.
• In vivo and in vitro assays to assess lipid antigen presentation and NKT cell activation.
• Screening of lipid libraries for compounds with anti-tumor activity.

Main Results:

• Successful generation of a humanized mouse model recapitulating human CD1d-NKT cell interactions.
• Identification of specific lipid candidates that potently activate NKT cells.
• Demonstration of NKT cell-mediated tumor suppression in the humanized model.

Conclusions:

• Humanized mouse models are valuable tools for dissecting CD1d-NKT cell interactions in cancer immunology.
• This platform facilitates the discovery of novel lipid-based immunotherapeutics.
• Preclinical validation in humanized systems can accelerate the development of effective NKT-cell-targeting anticancer drugs.